【摘 要】
：
Background:We assessed baseline and on-treatment variables to determine predictive factors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir therapy.
【机 构】
：
Soonchunhyang University Hopsital
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
论文部分内容阅读
Background:We assessed baseline and on-treatment variables to determine predictive factors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir therapy.
其他文献
Background:To investigated the short term efficacies of telbivudine and entecavir as first-line agents for Hepatitis B virus(HBV) suppression in patients with HBV-related advanced Hepatocellular carci
Background:Hepatitis B virus is endemic in Korea with greater that 90 ％infected with genotype c.Entecavir(ETV) is a potent nucleoside analogue with high genetic barrier to resistance which has been a
Background:To investigate the clinical characteristics and outcome of HBV reactivation in hepatitis B surface antigen(HBsAg)-negative and hepatitis B core antibody(anti-HBc)-positive patients with hem
Background:Entecavair(ETV) 1mg monotherapy was sometimes used for the chronic hepatitis B(CHB)patients with other nucleoside resistance in the past,but now,not recommended due to sequential resistance
In patients with chronic liver diseases,identification of significant liver fibrosis and cirrhosis is essential for determining treatment strategies,assessing therapeutic response,and stratifying long
Background:Disruption of peripheral blood B-cell homeostasis and variation of surface receptors occur with certain infections and autoimmune diseases.However,the impact of antiviral therapy on B-cell
Background:The core promoter(CP) of hepatitis B virus(HBV) plays a central role in viral replication and morphogenesis.The aim of this study was to characterize CP deletion(Del)/insertion(Ins) mutatio
Background:Transforming growth factor β-activated kinase 1(TAK1) is a key mediator of innate immunity and proinflammatory signaling pathway.Previously,we found that TAK1 was involved in anti-HBV effec
Background:Seroclearance of HBsAg and HBeAg seroconversion are the important events in the natural history of the HBV infection.However,the spontaneous rates of HBsAg seroclearance,HBsAg seroconverion
Background:C-X-C-chemokine ligand 13(CXCL13),the ligand for C-X-C chemokine receptor type 5(CXCR5),is a major regulator of B-cell trafficking and plays an integral role in age-dependent clearance of H